Business & Industry
BioPharma
J&J To Be in Sync with Trump Administration as MFN Spreads
As the two Trump administration drug pricing deals find their place in the books and more that are likely on the way, the U.S. policy...
BioPharma
Investments in the U.S. of Over $70bn Announced by Merck
It is well to be noted that in 2025, a minimum of 14 major pharmaceutical companies across the world went ahead and announced plans to...
BioPharma
US Tariffs on Pharma Exports from Singapore Deferred
As originally reported by the Straits Times and also shared by Reuters, the enforcement of US tariffs on pharma exports from Singapore is being deferred so as...
Business & Industry
AstraZeneca Plant Expansion to Double Production of Lokelma
AstraZeneca has gone on to announce a newly expanded manufacturing facility located in Coppell, Texas, U.S., which is going to double production of Lokelma for the...
BioPharma
Advanced Drug Delivery Platforms Enhancing Bioavailability
Enhancing Bioavailability Through Advanced Drug Delivery Platforms
The pharmaceutical industry confronts an enduring challenge where promising therapeutic molecules fail clinical translation due to inadequate bioavailability. Advanced...
BioPharma
Innovative Formulation Strategies for Poorly Soluble Drugs
The pharmaceutical industry confronts a formidable obstacle that threatens to derail promising therapeutic candidates before they reach patients. Poor aqueous solubility afflicts over 70% of...
BioPharma
Anti-Counterfeit Technologies in Pharma Packaging
Anti-Counterfeit Technologies Strengthening Pharma Security
The pharmaceutical industry faces an unprecedented challenge from counterfeit medications that threaten patient safety, erode brand trust, and result in billions...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.